Total Payments
$1,875
2024 Payments
$302.85
Companies
9
Transactions
38
Medicare Patients
1,256
Medicare Billing
$133,047
Payment Breakdown by Category
Food & Beverage$1,150 (61.3%)
Other$725.00 (38.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,150 | 37 | 61.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $725.00 | 1 | 38.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $890.66 | 11 | $0 (2021) |
| Merz North America, Inc. | $353.71 | 4 | $0 (2022) |
| ABBVIE INC. | $337.35 | 13 | $0 (2024) |
| Novo Nordisk Inc | $159.70 | 3 | $0 (2024) |
| PFIZER INC. | $50.26 | 3 | $0 (2023) |
| AIMMUNE THERAPEUTICS, INC. | $23.60 | 1 | $0 (2024) |
| Exact Sciences Corporation | $23.03 | 1 | $0 (2024) |
| Lilly USA, LLC | $20.60 | 1 | $0 (2022) |
| Genentech USA, Inc. | $16.56 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $302.85 | 7 | ABBVIE INC. ($131.22) |
| 2023 | $45.38 | 2 | ABBVIE INC. ($26.81) |
| 2022 | $496.81 | 11 | Merz North America, Inc. ($353.71) |
| 2021 | $833.08 | 6 | Allergan, Inc. ($725.00) |
| 2020 | $41.67 | 2 | Allergan, Inc. ($41.67) |
| 2019 | $65.96 | 5 | Allergan Inc. ($53.96) |
| 2018 | $89.72 | 5 | Allergan Inc. ($70.03) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: FACIAL AESTHETICS | ||||||
| 07/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: FACIAL AESTHETICS | ||||||
| 04/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Oncology | ||||||
| 04/09/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $73.72 | General |
| 03/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
| 02/22/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/30/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: PAIN | ||||||
| 11/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: NEUROSCIENCE | ||||||
| 11/03/2022 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Immunology | ||||||
| 10/27/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: NEUROSCIENCE | ||||||
| 06/16/2022 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $164.97 | General |
| 06/16/2022 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $47.98 | General |
| 06/14/2022 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $73.06 | General |
| 06/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2022 | Merz North America, Inc. | — | Food and Beverage | In-kind items and services | $67.70 | General |
| 03/24/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Obesity | ||||||
| 04/14/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Obesity | ||||||
| 03/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/23/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 331 | 492 | $138,542 | $32,400 |
| 2022 | 8 | 318 | 466 | $148,236 | $35,708 |
| 2021 | 7 | 287 | 434 | $138,159 | $35,765 |
| 2020 | 9 | 320 | 499 | $141,028 | $29,175 |
Total Patients
1,256
Total Services
1,891
Medicare Billing
$133,047
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 66 | 66 | $35,354 | $10,811 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 131 | $44,195 | $9,561 | 21.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 82 | 138 | $26,971 | $5,265 | 19.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 32 | $15,988 | $3,288 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $7,480 | $1,975 | 26.4% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 17 | 43 | $4,060 | $811.78 | 20.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 26 | $1,144 | $247.52 | 21.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 29 | $644.60 | $243.60 | 37.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 16 | $2,706 | $197.54 | 7.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 74 | 74 | $38,669 | $12,562 | 32.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 82 | 158 | $51,933 | $10,929 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 48 | $23,418 | $4,385 | 18.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 71 | 98 | $18,707 | $4,049 | 21.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $8,767 | $2,826 | 32.2% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 15 | 42 | $3,612 | $685.04 | 19.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 17 | 19 | $2,850 | $229.10 | 8.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 13 | 14 | $280.00 | $41.49 | 14.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 83 | 171 | $56,206 | $13,154 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 64 | 64 | $33,471 | $11,054 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 71 | $34,639 | $8,726 | 25.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 35 | 40 | $7,636 | $1,935 | 25.3% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 12 | 28 | $2,408 | $537.12 | 22.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 18 | 20 | $3,000 | $239.20 | 8.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 35 | 40 | $800.00 | $120.00 | 15.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 75 | 155 | $50,947 | $10,075 | 19.8% |
About Dr. Gina Escobar, MD
Dr. Gina Escobar, MD is a Internal Medicine healthcare provider based in Fairbanks, Alaska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962560268.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gina Escobar, MD has received a total of $1,875 in payments from pharmaceutical and medical device companies, with $302.85 received in 2024. These payments were reported across 38 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,150).
As a Medicare-enrolled provider, Escobar has provided services to 1,256 Medicare beneficiaries, totaling 1,891 services with total Medicare billing of $133,047. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fairbanks, AK
- Active Since 12/05/2006
- Last Updated 06/08/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962560268
Products in Payments
- UBRELVY (Drug) $208.47
- Wegovy (Drug) $125.00
- VRAYLAR (Drug) $65.24
- BYSTOLIC (Drug) $44.99
- Saxenda (Drug) $34.70
- BOTOX (Biological) $34.25
- BOTOX COSMETIC (Biological) $25.48
- ZENPEP (Drug) $23.60
- QULIPTA (Drug) $23.25
- Cologuard Collection Kit (Device) $23.03
- MOUNJARO (Drug) $20.60
- LYRICA (Drug) $19.69
- NURTEC ODT (Drug) $18.57
- Xolair (Biological) $16.56
- SKYRIZI (Biological) $12.52
- CHANTIX (Drug) $12.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fairbanks
Dr. Arva Chiu, M.d, M.D
Internal Medicine — Payments: $1,396
Internal Medicine $1,396
Dr. Daniel Kechker, Do, DO
Internal Medicine — Payments: $493.81
Internal Medicine $493.81
Dr. Pierre Johnson, M.d, M.D
Internal Medicine — Payments: $327.93
Internal Medicine $327.93
Dr. David Grauman, M.d., P.c., M.r.o, M.D., P.C., M.R.O
Internal Medicine — Payments: $107.72
Internal Medicine $107.72
Dr. Michael Swenson, M.d, M.D
Internal Medicine — Payments: $70.11
Internal Medicine $70.11
Bruce Footit, Md, MD
Internal Medicine — Payments: $62.62
Internal Medicine $62.62